Sorry, you need to enable JavaScript to visit this website.

Stryker Hip/ABG II - Case Information


Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem are manufactured by Howmedica Osteonics Corporation, a New Jersey corporation d/b/a Stryker Orthopaedics, hereinafter, HOC. On July 3, 2012, HOC voluntarily recalled the hip stems "due to the potential risks associated with modular-neck stems. These risks include the potential for fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reactions manifesting with pain and/or swelling." Possible adverse outcomes allegedly include metallosis, necrosis and osteolysis. On January 15, 2013, the New Jersey Supreme Court designated this litigation as multicounty litigation and assigned the handling of all pending and future state cases involving these components to Bergen County to be handled by Judge Rachelle L. Harz.

Counsel is reminded that as a requirement to participate in mediation, they must notify defense counsel within thirty (30) days of service of their complaint.